NK cell culture fluid for efficient in-vitro amplification and NK cell culture method

By optimizing the formulation and steps of NK cell culture medium, the in vitro amplification effect of NK cells is improved, the problems of poor stability and amplification effect in the existing technology are solved, and efficient and stable NK cell preparation is achieved, which is suitable for Large-scale production and clinical application.

CN118931836APending Publication Date: 2024-11-12SHENZHEN BEIKE BIOTECH
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411051237.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing NK cell in vitro expansion culture system has poor stability and poor cell expansion effect, resulting in low number, viability and purity of NK cells, which is difficult to meet the treatment needs.

Method used

Using high-efficiency in vitro amplification NK cell culture medium consisting of basal culture medium, albumin, DPBS, IL-2, L-5, IL-7, IL-21 and anti-human CD28 antibodies, the culture steps and liquid combinations were optimized. It can improve cell viability and quantity, and is suitable for the large-scale production of NK cells.

Benefits of technology

It has achieved efficient in vitro expansion of NK cells, with cell viability reaching more than 80%, sufficient quantity and improved stability, and is suitable for a variety of application needs in clinical and academic research.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118931836A_ABST
    Figure CN118931836A_ABST
Patent Text Reader

Abstract

The invention discloses an NK cell culture solution for efficient in-vitro amplification and an NK cell culture method, and relates to the technical field of immune cells, the NK cell culture solution for efficient in-vitro amplification comprises a first culture solution and a second culture solution, the first culture solution is composed of a basic culture medium, albumin, DPBS, IL-2, L-5, IL-7, IL-21 and an anti-human CD28 antibody; the first culture solution is prepared by adding 4%-15% of albumin, 3%-5% of DPBS, IL-2 with the concentration of 1000-2500 iU / mL, IL-5 with the concentration of 50-100 [mu] g / mL, IL-7 with the concentration of 10-50 [mu] g / mL, IL-21 with the concentration of 5-50 [mu] g / mL and an anti-human CD28 antibody with the concentration of 10-140 [mu] g / mL into a basic culture medium; the second culture solution is prepared by adding 0.1%-2% of DPBS, IL-2 with the concentration of 1000-2500 iU / mL and an anti-human CD28 antibody with the concentration of 10-140 ug / mL into a basic culture medium; the cell viability of the cells cultured by the method reaches more than 80%, the number is sufficient, and the cells are stable; the method has high value for large-scale production of the NK cells, and is suitable for popularization and application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technology of immune cell field, and in particular to a NK cell culture fluid and a NK cell culture method for efficient in vitro expansion. Background Art

[0002] NK cells are a group of large granular lymphocytes that can spontaneously dissolve a variety of tumor cells and virus-infected cells. They are called natural killer cells. Because they lack specific markers of T cells and B cells such as TCR and BCR on their surface, they are also called naked cells. NK cells are independent of antigen stimulation and are mainly found in peripheral blood and spleen, accounting for 5%-10% of lymphocytes in human peripheral blood. Compared with T cells and B cells, the specificity of NK cell surface markers is relative. Some NK cells are CD2, CD3 and CD8 positive, express IL-2 receptor β chain (P75, CD122), and are CD11b / CD18 positive. Common markers for detecting NK cells are CD16, CD56, CD3, CD59, CD11b, CD94 and LAK-1.

[0003] NK cells are important immune cells in the body and a barrier to the human body's defense system. While removing damaged cells, aging cells, foreign bacteria, viruses and cancerous cells, NK cells also have strong immunoregulatory functions, interacting with other immune cells to regulate the body's immune status and immune function. Clinical studies have also found that NK cells can activate new cells, accelerate the body's metabolic cycle, help the body recover, delay aging, and maintain a youthful state. However, NK cells will not always be strong. NK cells will gradually decrease as the body ages and develops, and their combat effectiveness will continue to decline. Factors such as age, stress, lack of sleep, overwork, malnutrition, and exposure to pathogens and toxins will reduce the activity of NK cells, causing them to be defeated in the face of diseased cells.

[0004] At present, in the process of in vitro expansion and culture of NK cells, ALyS505NK-EX culture medium is often used as the main culture medium, and IL-2 and IL-15 are used as cytokines to stimulate in vitro expansion of NK cells. However, various research results show that the stability of the above culture system is poor, the cell expansion effect is poor or even fails, and the number, viability and purity of the expanded NK cells are low. Therefore, efficient in vitro expansion of NK cell culture fluid and NK cell culture method has become one of the key issues in NK cell therapy. Summary of the invention

[0005] In view of this, the present invention aims to address the deficiencies in the prior art, and its main purpose is to provide a NK cell culture medium and a NK cell culture method for efficient in vitro expansion. The cells cultured according to the present invention have a cell viability of more than 80%, and are sufficient in number and stable in cells. The present invention has high value for the large-scale production of NK cells and is suitable for promotion and application.

[0006] To achieve the above purpose, the present invention adopts the following technical solutions:

[0007] A highly efficient NK cell culture fluid for in vitro expansion comprises a first culture fluid and a second culture fluid, wherein the first culture fluid is composed of a basal culture medium, albumin, DPBS, IL-2, L-5, IL-7, IL-21 and an anti-human CD28 antibody; and the second culture fluid is composed of a basal culture medium, DPBS, IL-2 and an anti-human CD28 antibody.

[0008] As a preferred embodiment: the first culture fluid is a basal culture medium to which is added 4%-15% albumin, 3%-5% DPBS, 1000-2500iU / mL IL-2, 50-100ug / mL IL-5, 10-50ug / mL IL-7, 5-50ug / mL IL-21 and 10-140ug / mL anti-human CD28 antibody.

[0009] As a preferred embodiment: the first culture fluid is a basal culture medium with 8% albumin, 3% DPBS, 1500iU / mL IL-2, 70ug / mL IL-5, 45ug / mL IL-7, 45ug / mL IL-21 and 70ug / mL anti-human CD28 antibody added thereto; the basal culture medium is Serum-free medium for T cell expansion.

[0010] As a preferred solution: the second culture fluid is a basal culture medium with 0.1%-2% DPBS, 1000-2500iU / mL IL-2 and 10-140ug / mL anti-human CD28 antibody added thereto.

[0011] As a preferred embodiment: the second culture medium is a basal culture medium with 2% DPBS, 1500iU / mL IL-2 and 140ug / mL anti-human CD28 antibody added thereto; the basal culture medium is Serum-free medium for T cell expansion.

[0012] The NK cell culture method using a high-efficiency in vitro expansion NK cell culture medium comprises the following steps:

[0013] S1. After mononuclear cells are recovered, add basal culture medium and centrifuge, retain the supernatant and obtain cell pellet;

[0014] S2, adding the cell precipitate in step S1 to 20%-25% of the first culture medium, mixing, sampling and counting, and culturing in a CO2 incubator at 37° C. and 5% CO2;

[0015] S3, adding liquid on the third day, adding 20%-30% of the first culture solution;

[0016] S4, on the 5th day, add 45%-60% of the first culture medium;

[0017] S5. On the 7th day, the bottle is blown and 5%-10% of the second culture solution is added;

[0018] S6. On the 9th day, expand the bottle by adding 10%-20% of the second culture medium to expand the bottle, mix well, and divide equally into two culture bottles;

[0019] S7. On the 11th day, the bag transfer operation is performed, using the second culture medium to transfer the bags, with 10%-15% of the second culture medium transferred into each culture bag, for a total of 2 culture bags;

[0020] S8. On the 14th day, the second culture solution is used for rehydration, and each culture bag is rehydrated with 10%-15% of the second culture solution; on the 16th day and the 19th day, the second culture solution is also used for rehydration, and each culture bag is rehydrated with 2.5%-10% of the second culture solution;

[0021] S9. On day 22, cells were collected.

[0022] As a preferred solution: in step S1, the mononuclear cells are derived from cord blood or peripheral blood, the number of which is not less than 1 million, the temperature during resuscitation is 37-40 degrees Celsius, and the centrifugation parameters are: 300-500g, 8-10min.

[0023] As a preferred solution: Steps S6, S7 and S8 all require counting and observation before operation, and the counting density in step S6 is not less than 1.0*10 6 The counting density in step S7 is not less than 1.5*10 6 After the bag transfer, a certain amount of each culture bag needs to be taken for bacteria and fungi detection; the counting density in step S8 is not less than 1*10 6 / mL. If the density is lower than this, delay for 1-2 days.

[0024] As a preferred solution: the normal culture time of NK cells in step S9 is 22 days. The cells are observed and counted during 22 days, and the cells can be harvested when the number is greater than 6 billion. When harvesting, the cells are taken out, the cell surface is washed with physiological saline, the cell viability, number and cell phenotype are detected, and the remaining cells are frozen.

[0025] As a preferred solution: in the steps S1 to S9, the culture bottles are placed in an incubator at 37° C. and 5% CO 2 , and when the cell culture bottles are taken out from the incubator, they are moved out horizontally using a horizontal tray.

[0026] Compared with the prior art, the present invention has obvious advantages and beneficial effects. Specifically, it can be seen from the above technical scheme that the cells cultured according to the present invention have a cell viability of more than 80%, and the number is sufficient and the cells are stable; the present invention has high value for the large-scale production of NK cells and is suitable for promotion and application; the large-scale preparation of NK cells is completed by optimizing and improving the inoculation, amplification and cell harvesting steps of mononuclear cells; the beneficial effects of the present invention: the method can be used for large-scale amplification in vitro, and the operation is simple, and the obtained NK cells have a high viability, which can meet the various application needs of clinical or academic research.

[0027] In order to more clearly illustrate the structural features and effects of the present invention, it is described in detail below in conjunction with the accompanying drawings and specific embodiments. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 This is a schematic diagram of the growth curves of the six experimental groups cultured in Example 1 of the present invention. DETAILED DESCRIPTION

[0029] The present invention Figure 1 As shown, a high-efficiency NK cell culture fluid for in vitro expansion includes a first culture fluid and a second culture fluid, wherein the first culture fluid is composed of a basal culture medium, albumin, DPBS, IL-2, L-5, IL-7, IL-21 and anti-human CD28 antibodies; the second culture fluid is composed of a basal culture medium, DPBS, IL-2 and anti-human CD28 antibodies.

[0030] The first culture medium is prepared by adding 4%-15% albumin, 3%-5% DPBS, 1000-2500iU / mL IL-2, 50-100ug / mL IL-5, 10-50ug / mL IL-7, 5-50ug / mL IL-21 and 10-140ug / mL anti-human CD28 antibody to a basic culture medium.

[0031] The first culture fluid is prepared by adding 8% albumin, 3% DPBS, 1500iU / mL IL-2, 70ug / mL IL-5, 45ug / mL IL-7, 45ug / mL IL-21 and 70ug / mL anti-human CD28 antibody to a basic culture medium; the basic culture medium is Serum-free medium for T cell expansion.

[0032] The second culture fluid is prepared by adding 0.1%-2% DPBS, 1000-2500 iU / mL IL-2 and 10-140 ug / mL anti-human CD28 antibody into the basic culture medium.

[0033] The second culture fluid is prepared by adding 2% DPBS, 1500 iU / mL IL-2 and 140 ug / mL anti-human CD28 antibody to the basic culture medium; the basic culture medium is Serum-free medium for T cell expansion.

[0034] The NK cell culture method using a high-efficiency in vitro expansion NK cell culture fluid comprises the following steps:

[0035] S1. After mononuclear cells are recovered, add basal culture medium and centrifuge, keep the supernatant to obtain cell pellet; keep the supernatant until the end of cryopreservation;

[0036] S2, adding the cell precipitate in step S1 to 20%-25% of the first culture medium, mixing, sampling and counting, and culturing in a CO2 incubator at 37° C. and 5% CO2;

[0037] S3, adding liquid on the third day, adding 20%-30% of the first culture solution;

[0038] S4, on the 5th day, add 45%-60% of the first culture medium;

[0039] S5. On the 7th day, the bottle is blown and 5%-10% of the second culture solution is added;

[0040] S6. On the 9th day, expand the bottle by adding 10%-20% of the second culture medium to expand the bottle, mix well, and divide equally into two culture bottles;

[0041] S7. On the 11th day, the bag transfer operation is performed, using the second culture medium to transfer the bags, with 10%-15% of the second culture medium transferred into each culture bag, for a total of 2 culture bags;

[0042] S8. On the 14th day, the second culture solution is used for rehydration, and each culture bag is rehydrated with 10%-15% of the second culture solution; on the 16th day and the 19th day, the second culture solution is also used for rehydration, and each culture bag is rehydrated with 2.5%-10% of the second culture solution;

[0043] S9. On day 22, cells were collected.

[0044] The first culture medium needs to be rewarmed before use, and the cell status needs to be observed before operation.

[0045] The second culture medium needs to be placed at room temperature for 30 minutes to rewarm before use.

[0046] In step S1, the mononuclear cells are derived from cord blood or peripheral blood, and the number of the mononuclear cells is not less than 1 million. The temperature during recovery is 37-40 degrees Celsius, and the centrifugation parameters are: 300-500g, 8-10min.

[0047] Steps S6, S7 and S8 all require counting and observation before operation. The counting density in step S6 is not less than 1.0*10 6 The counting density in step S7 is not less than 1.5*10 6 After the bag transfer, a certain amount of each culture bag needs to be taken for bacteria and fungi detection; the counting density in step S8 is not less than 1*10 6 / mL. If the density is lower than this, delay for 1-2 days.

[0048] The normal culture time of NK cells in step S9 is 22 days. During the 22 days, the cells are observed and counted. When the number is greater than 6 billion, the cells can be harvested. When harvesting, the cells are taken out, the cell surface is washed with physiological saline, the cell viability, number and cell phenotype are tested, and the remaining cells are cryopreserved.

[0049] In step S1 to step S9, the culture flasks are placed in an incubator at 37° C. and 5% CO 2 , and when the cell culture flasks are taken out from the incubator, they are moved out horizontally using a horizontal tray, avoiding the use of hands.

[0050] Example 1: The present invention provides a highly efficient in vitro expansion NK cell culture medium comprising a first culture medium and a second culture medium, wherein the first culture medium is 8 mL of albumin, 3 mL of DPBS, 1500 iU / mL of IL-2, 70 ug / mL of IL-5, 45 ug / mL of IL-7, 45 ug / mL of IL-21, and 70 ug / mL of anti-human CD28 antibody were added to the T cell expansion serum-free medium (80 mL); the second culture medium was 2 mL of DPBS, 1500 iU / mL / mL IL-2, and 140 ug / mL anti-human CD28 antibody were added to T cell expansion serum-free medium (2000 mL).

[0051] Example 2: The NK cell culture method of the present invention using a high-efficiency in vitro expansion NK cell culture medium comprises the following steps:

[0052] S1: After peripheral blood mononuclear cells were recovered, add Centrifuge 40 mL of T cell serum-free culture medium and keep the supernatant.

[0053] S2: Prepare the first culture medium; inoculate the cell pellet in step 1 into 20 mL of the prepared first culture medium, mix well, take samples and count, and culture in a CO2 incubator at 37° C. and 5% CO2.

[0054] S3: On the third day, add 20 mL of the first culture medium.

[0055] S4: On the 5th day, add 40 mL of the first culture medium.

[0056] S5: prepare the second culture solution; on the 7th day, perform bottle blowing operation and add 200 mL of the second culture solution.

[0057] S6: On the 9th day, expand the bottle with the second culture medium, add 200 mL, and divide it equally into 2 culture bottles.

[0058] S7: On the 11th day, the bag transfer operation was performed using the second culture medium. About 200 mL of the second culture medium was transferred into each culture bag, for a total of 2 culture bags.

[0059] S8: On the 14th day, the second culture solution was used for rehydration, with 400 mL of the second culture solution added to each bag; on the 16th and 19th days, the second culture solution was also used for rehydration, with 100 mL of the second culture solution added to each bag.

[0060] S9: Collect cells at 22nd day.

[0061] Depend on Figure 1 It can be seen that the proliferation ability of the NK cells described in the present invention is that the NK cells cultured in the present invention have an adaptation period of 0-14 days, a logarithmic growth period of 14-19 days, and rapid cell proliferation. From day 19 to day 22, cell proliferation slows down and enters a plateau period, and the number reaches 6 billion; indicating that the proliferation ability of the NK cells cultured in the present invention is relatively strong.

[0062] Example 3: In order to more clearly reflect the technical solution of the present invention, the cells collected in Example 1 were subjected to cell viability detection, cell number detection, and flow cytometry detection.

[0063] The culture results were statistically analyzed, including cell viability detection using trypan blue staining, cell number detection using dual fluorescence counting method, and flow cytometry detection using flow cytometer.

[0064] The statistical results are shown in Table 1:

[0065]

[0066] As can be seen from Table 1 above, the cell activity of the NK cells of the present invention is higher than 84% after culturing for 22 days in experimental groups 1 to 6; the number of cells after culture is higher than 7 billion, and the number of CD16+CD56+ cells accounts for a high proportion in the flow cytometry results, which shows that the cell activity of the NK cells of the present invention is higher.

[0067] Example 4: In order to investigate the safety of NK cell serum-free medium cultured cells of the present invention, the cells collected in Example 1 were subjected to bacterial and fungal detection, mycoplasma detection, and endotoxin detection. Among them, the bacteria and fungi detection adopts the full-automatic microbial culture system detection method to detect bacteria and fungi on the specimens; the mycoplasma detection refers to the direct culture method of the Chinese Pharmacopoeia to detect the specimens; the endotoxin detection refers to the horseshoe crab reagent gel method specified in the Chinese Pharmacopoeia to detect the specimens.

[0068] The test results are shown in Table 2:

[0069]

[0070] As shown in Table 2, after 22 days of culture, the bacterial and fungal tests and mycoplasma tests of the cells were all negative, and the endotoxin test of the cells was less than 0.5EU / mL. This shows that the safety of the NK cells described in the present invention is relatively high.

[0071] Example 5: In order to more clearly reflect the technical solution of the present invention, this solution and ALyS505NK-EX culture medium were cultured under the same conditions after adding the inducer recommended by the manufacturer, and a comparison was made, and the culture results were statistically analyzed;

[0072] The statistical results are shown in Table 3:

[0073]

[0074]

[0075] It can be seen from Table 3 above that the cell viability of the culture medium used in the present invention is greater than 80% and there is almost no difference between the cells cultured in the ALyS505NK-EX culture medium and the cells cultured in the ALyS505NK-EX culture medium. However, the number of cells collected after 22 days of culture using the culture medium of the present invention is much higher than that of the ALyS505NK-EX culture medium, and the CD16+CD56+ ratio is also higher than that of the cells cultured in the ALyS505NK-EX culture medium.

[0076] The design focus of the present invention is that the cells cultured according to the present invention have a cell viability of more than 80%, and the number is sufficient and the cells are stable; the present invention has high value for the large-scale production of NK cells and is suitable for promotion and application; by optimizing and improving the inoculation, amplification and cell harvesting steps of mononuclear cells, large-scale preparation of NK cells is completed; the beneficial effects of the present invention: the method can be used for large-scale in vitro amplification, and the operation is simple, and the obtained NK cells have a high viability, which can meet various application needs of clinical or academic research.

[0077] The above description is only a preferred embodiment of the present invention and does not limit the technical scope of the present invention. Therefore, any slight modifications, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention are still within the scope of the technical solution of the present invention.

Claims

1. A highly efficient NK cell culture medium for in vitro expansion, characterized in that: The invention comprises a first culture fluid and a second culture fluid, wherein the first culture fluid is composed of a basal culture fluid, albumin, DPBS, IL-2, L-5, IL-7, IL-21 and anti-human CD28 antibody; and the second culture fluid is composed of a basal culture fluid, DPBS, IL-2 and anti-human CD28 antibody.

2. The NK cell culture medium for efficient in vitro expansion according to claim 1, characterized in that: The first culture medium is prepared by adding 4%-15% albumin, 3%-5% DPBS, 1000-2500iU / mL IL-2, 50-100ug / mL IL-5, 10-50ug / mL IL-7, 5-50ug / mL IL-21 and 10-140ug / mL anti-human CD28 antibody to the basic culture medium.

3. The NK cell culture medium for efficient in vitro expansion according to claim 2, characterized in that: The first culture fluid is a basal culture medium containing 8% albumin, 3% DPBS, 1500iU / mL IL-2, 70ug / mL IL-5, 45ug / mL IL-7, 45ug / mL IL-21 and 70ug / mL anti-human CD28 antibody; the basal culture medium is Serum-free medium for T cell expansion.

4. The NK cell culture medium for efficient in vitro expansion according to claim 1, characterized in that: The second culture solution is prepared by adding 0.1%-2% DPBS, 1000-2500 iU / mL IL-2 and 10-140 ug / mL anti-human CD28 antibody to the basic culture medium.

5. The NK cell culture medium for high-efficiency in vitro expansion according to claim 4, characterized in that: The second culture fluid is a basal culture medium with 2% DPBS, 1500iU / mL IL-2 and 140ug / mL anti-human CD28 antibody added thereto; the basal culture medium is Serum-free medium for T cell expansion.

6. A method for culturing NK cells using the NK cell culture medium for efficient in vitro expansion according to any one of claims 1 to 5, characterized in that: The steps include: S1. After mononuclear cells are recovered, add basal culture medium and centrifuge, retain the supernatant and obtain cell pellet; S2, adding the cell precipitate in step S1 to 20%-25% of the first culture medium, mixing, sampling and counting, and culturing in a CO2 incubator at 37° C. and 5% CO2; S3, adding liquid on the third day, adding 20%-30% of the first culture solution; S4, on the 5th day, add 45%-60% of the first culture medium; S5. On the 7th day, the bottle is blown and 5%-10% of the second culture solution is added; S6. On the 9th day, expand the bottle by adding 10%-20% of the second culture medium to expand the bottle, mix well, and divide equally into two culture bottles; S7. On the 11th day, the bag transfer operation is performed, using the second culture medium to transfer the bags, with 10%-15% of the second culture medium transferred into each culture bag, for a total of 2 culture bags; S8. On the 14th day, the second culture solution is used for rehydration, and each culture bag is rehydrated with 10%-15% of the second culture solution; on the 16th day and the 19th day, the second culture solution is also used for rehydration, and each culture bag is rehydrated with 2.5%-10% of the second culture solution; S9. On day 22, cells were collected.

7. The NK cell culture method according to claim 6, characterized in that: In step S1, the mononuclear cells are derived from cord blood or peripheral blood, and the number of the mononuclear cells is not less than 1 million. The temperature during resuscitation is 37-40 degrees Celsius, and the centrifugation parameters are: 300-500g, 8-10min.

8. The NK cell culture method according to claim 6, characterized in that: Steps S6, S7 and S8 all require counting and observation before operation, and the counting density in step S6 is not less than 1.0*10 6 The counting density in step S7 is not less than 1.5*10 6 After the bag transfer, a certain amount of each culture bag needs to be taken for bacteria and fungi detection; the counting density in step S8 is not less than 1*10 6 / mL. If the density is lower than this, delay for 1-2 days.

9. The NK cell culture method according to claim 6, characterized in that: The normal culture time of NK cells in step S9 is 22 days. The cells are observed and counted during the 22 days. When the number is greater than 6 billion, the cells can be harvested. When harvesting, the cells are taken out, the cell surface is washed with physiological saline, the cell viability, number and cell phenotype are tested, and the remaining cells are frozen.

10. The NK cell culture method according to claim 6, characterized in that: In the steps S1 to S9, the culture bottles are placed in an incubator at 37° C. and 5% CO 2 , and when the cell culture bottles are taken out from the incubator, they are moved out horizontally using a horizontal tray.

Citation Information

Cited By

  • NK cell in-vitro amplification culture medium and culture method thereof

    CN120158426A